Ma W - Search Results

1

Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease.

Qu KZ, Zhang K, Ma W, Li H, Wang X, Zhang X, Giles F, Lai M, Afdhal NH, Albitar M. Qu KZ, et al. Among authors: ma w. J Gastroenterol Hepatol. 2011 Apr;26(4):751-8. doi: 10.1111/j.1440-1746.2010.06491.x. J Gastroenterol Hepatol. 2011. PMID: 21418304

2

Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemia.

Ma W, Tseng R, Gorre M, Jilani I, Keating M, Kantarjian H, Cortes J, O'Brien S, Giles F, Albitar M. Ma W, et al. Haematologica. 2007 Feb;92(2):170-5. doi: 10.3324/haematol.10360. Haematologica. 2007. PMID: 17296565 Free article.

3

Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.

Ma W, Kantarjian H, O'Brien S, Jilani I, Zhang X, Estrov Z, Ferrajoli A, Keating M, Giles F, Albitar M. Ma W, et al. Cancer. 2008 Mar 15;112(6):1306-12. doi: 10.1002/cncr.23301. Cancer. 2008. PMID: 18224667 Free article.

4

Higher detection rate of JAK2 mutation using plasma.

Ma W, Kantarjian H, Zhang X, Sun W, Buller AM, Jilani I, Schwartz JG, Giles F, Albitar M. Ma W, et al. Blood. 2008 Apr 1;111(7):3906-7. doi: 10.1182/blood-2008-02-139188. Blood. 2008. PMID: 18362222 Free article. No abstract available.

5

BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations.

Lee TS, Ma W, Zhang X, Giles F, Cortes J, Kantarjian H, Albitar M. Lee TS, et al. Among authors: ma w. Mol Cancer Ther. 2008 Dec;7(12):3834-41. doi: 10.1158/1535-7163.MCT-08-0482. Epub 2008 Dec 3. Mol Cancer Ther. 2008. PMID: 19056677

6

Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.

Ma W, Kantarjian H, Zhang X, Yeh CH, Zhang ZJ, Verstovsek S, Albitar M. Ma W, et al. J Mol Diagn. 2009 Jan;11(1):49-53. doi: 10.2353/jmoldx.2009.080114. Epub 2008 Dec 12. J Mol Diagn. 2009. PMID: 19074595 Free PMC article.

7

Mechanisms of constitutive activation of Janus kinase 2-V617F revealed at the atomic level through molecular dynamics simulations.

Lee TS, Ma W, Zhang X, Giles F, Kantarjian H, Albitar M. Lee TS, et al. Among authors: ma w. Cancer. 2009 Apr 15;115(8):1692-700. doi: 10.1002/cncr.24183. Cancer. 2009. PMID: 19195039 Free article.

8

K-ras mutations and cetuximab in colorectal cancer.

Albitar M, Yeh C, Ma W. Albitar M, et al. Among authors: ma w. N Engl J Med. 2009 Feb 19;360(8):834; author reply 835-6. N Engl J Med. 2009. PMID: 19238675 No abstract available.

9

Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications.

Ma W, Kantarjian H, Zhang X, Jilani I, Sheikholeslami MR, Donahue AC, Ravandi F, Estey E, O'Brien S, Keating M, Giles FJ, Albitar M. Ma W, et al. Cancer Biomark. 2009;5(1):51-8. doi: 10.3233/CBM-2009-0583. Cancer Biomark. 2009. PMID: 19242062 Clinical Trial.

10

BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors.

Ma W, Kantarjian H, Yeh CH, Zhang ZJ, Cortes J, Albitar M. Ma W, et al. Acta Haematol. 2009;121(1):27-31. doi: 10.1159/000210060. Epub 2009 Mar 31. Acta Haematol. 2009. PMID: 19332983 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,779 results

Search Page

Filters